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Background & aims: Crohn's disease (CD) is a chronic intestinal disorder of unknown etiology involving
any section of the gastrointestinal tract often associated with protein-energy malnutrition (PEM).
Increased resting energy expenditure (REE) unmatched by adequate dietary intake is amongst the
pathogenetic mechanisms proposed for PEM. Aim of this study was to evaluate REE in CD patients
receiving or not immuno-suppressive therapy as compared to controls.
Methods: 36 CD patients (22 M and 14 F, age range 18e55 years) clinically stable and without compli-
cations since at least 6 month were studied. REE was evaluated by indirect calorimetry and body
composition by BIA. Full biochemistry was performed. Patients were divided into two groups: Group 1
(G1 ¼ 12 patients) without and Group 2 (G2 ¼ 24 patients) with immuno-suppressive therapy.
Results: The two groups were similar for age, height and BMI whereas signiﬁcantly differed for weight
(G1 vs G2: 56.9 ± 7.44 vs 62.3 ± 8.34 kg), fat free mass (FFM: 40.4 ± 5.73 vs 48.2 ± 7.06 kg), fat mass (FM:
17.0 ± 3.55 vs 13.9 ± 5.54 kg) and phase angle (PA: 5.6 ± 1.4 vs 6.5 ± 1.0). Serum inﬂammation pa-
rameters were signiﬁcantly higher in G1 than in G2: hs-PCR: 7.76 ± 14.2 vs 7.16 ± 13.4 mg/dl; alfa 2-
protein: 11.7 ± 3.69 vs 9.74 ± 2.08 mg/dl; ﬁbrinogen: 424 ± 174 vs 334 ± 118 mg/dl (p < 0.05). REE
was higher in G2 vs G1: 1383 ± 267 vs 1582 ± 253 kcal/die (p < 0.05) both in men: 1579 ± 314 vs
1640 ± 203 and women: 1267 ± 140 vs 1380 ± 132. Nevertheless, when corrected for FFM, REE resulted
higher in G1 than G2 (34.8 ± 4.89 vs 33.0 ± 4.35 kcal/kg, p < 0.05) group, also higher compared to our,
age and sex matched, control population (REE/FFM: 30.9 ± 4.5 kcal/kg).
Conclusions: Our preliminary results show that REE when adjusted for FFM is increased in clinically
stable CD patients and mildly reduced by immunosuppressive therapy possibly through a direct action
on inﬂammation and on body composition characteristics.
© 2016 The Authors. Published by Elsevier Ltd and European Society for Clinical Nutrition and
Metabolism. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Crohn's disease (CD) is a chronic inﬂammatory bowel disease
(IBD) of unknown etiology, which may involve any section of the
gastrointestinal tract. Malnutrition is frequently observed in pa-
tients with CD due to reduced nutrients absorption for the in-
ﬂammatory involvement of intestinal mucosa, mechanical
obstruction or wide intestinal resections. These factors may act
alone or combined, impairing gut ability to maintain protein-
energy, ﬂuid, electrolyte or micronutrient balance. Moreovericine and Surgery, Federico II
Italy. Tel.: þ39 0817462333;
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.01.005anorexia and catabolic effects of systemic inﬂammation could
contribute to cause weight loss and nutritional deﬁciencies [1,2].
As far as energy expenditure, several studies [3e6] evaluated
the accuracy of REE predictive equations also in CD pediatric pa-
tients with conﬂicting results. AzcueM et al. [7] studied the effect of
prednisolone on REE in children with Crohn's disease and found
that when REE is corrected for FFM, it does not differ as compared
with control group. More recently Wiskin AE et al. [8] studied in
sixty children the effect of disease activity, evaluated clinically and
by systemic and stool inﬂammatory markers, and reported that
REE/FFM corrected for physiologically relevant confounders was
not associated with disease activity.
At our knowledge there is only one study in adult CD patients on
the relation between REE and disease activity: Vaisman N et al. [9]cal Nutrition and Metabolism. This is an open access article under the CC BY-NC-ND
penditure in adult patients with Crohn's disease, Clinical Nutrition
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the presence of similar energy intake, REE does not seem to
contribute to lower BMI; therefore malabsorption should be indi-
rectly considered the main pathogenetic mechanism of malnutri-
tion in CD.
Aim of our study was to evaluate REE, expressed as total value or
corrected for FFM unit, in clinically stable adult Crohn's Disease
patients, receiving or not immuno-suppressive therapy and corre-
late REEwith body composition parameters as compared to age and
sex matched control group.Table 1
Anthropometric measurements, body composition and REE of untreated (group 1)
and treated (group 2) clinically stable CD patients.
Group 1 Group 2
n.12 n.24
Mean SD Mean SD
Age years 33.3 8.8 33.2 13.1
Weight kg 56.9* 7.4 62.3 8.3
Height cm 168 11 170 8
BMI kg/m2 20.3 2.3 21.5 2.5
FFM kg 40.4* 5.73 48.2 7.06
FAT kg 17.0* 3.55 13.9 5.54
PA degrees 5.6* 1.4 6.5 1.0
REE kcal/die 1383* 266 1583 253
REE/FFM kcal/kg 34.8 4.9 33.0 4.3
*p < 0.05 group 1 vs group 2.2. Materials and methods
36 Crohn disease patients (22 men and 14 women, age range
18e55 years), clinically and nutritionally stable since at least 6
months, consecutively undergoing a routine clinical nutritional
counselling at the Clinical Nutrition Outpatient Unit, Department of
Clinical Medicine and Surgery Federico II University Hospital in
Naples from 2007 to 2013 were included in this study.
Patients with ﬁstulae, ileostomy, or colostomy impairing ab-
sorption or with other associated metabolic, endocrine and organ
or apparatus complications were excluded.
All measurements were performed in fasting conditions early in
the morning.
Weight was measured to the nearest 0.1 kg using a platform
beam scale and height to the nearest 0.5 cm using a stadiometer
(Seca 709; Seca, Hamburg, Germany). BMI was calculated as weight
(kg) divided by squared of height (m). Bioimpedance analysis (BIA)
was performed at 50 kHz (Human Im Plus II, DS Medica) at room
temperature of 22e25 C. Measurements were carried out on the
non-dominant side of the body in the post-absorptive state, after
being in the supine position for 20 min [10]. The measured BIA
variables were resistance (Rp) and phase angle (PA) [11]; Fat Free
Mass (FFM) and Fat Mass (FM) were estimated using the prediction
equations developed by Kushner [12].
This parameter, deriving from arctangent of resistance and
reactance ratio, can be considered a prognostic index of the
integrity of the cell membrane. It identiﬁes extra/intracellular wa-
ter distribution: a low phase angle being a common ﬁnding in se-
vere malnutrition [13].
Resting Energy Expenditure was measured (REE) by indirect
calorimetry using a canopy system (V max29, Sensor Medics, An-
aheim, U.S.A.) at an ambient temperature of 23e25 C. The in-
strument was checked by burning ethanol while oxygen and
carbon dioxide analyzers were calibrated using nitrogen and
standardized gases (mixtures of nitrogen, carbon dioxide and ox-
ygen). Subjects were in the post-absorptive condition (12e14 h
fasting), lying down on the bed, in a quiet environment. Females of
child bearing age were evaluated in the immediate post menstrual
phase. After a 15 min adaptation period, oxygen consumption and
carbon dioxide production were determined for 45 min. The inter-
day coefﬁcient of variation (as determined in six individuals on
subsequent days) was less than 3%. Energy expenditure was then
calculated employing the abbreviated Weir's formula, neglecting
protein oxidation [10].
Blood samples were collected for routine biochemistry and
inﬂammation parameters (C-reactive protein, ﬁbrinogen and alfa 2
protein); all measurements were determined by routine laboratory
methods at the Department of Laboratory Medicine of the Uni-
versity Hospital Federico II, Naples.
Patients were divided into two groups:
 G1: Group 1 (12 patients; M¼ 4, F¼ 8) without pharmacological
treatmentPlease cite this article in press as: Sammarco R, et al., Resting energy ex
(2016), http://dx.doi.org/10.1016/j.clnu.2016.01.005 G2: Group 2 (24 patients; M ¼ 18, F ¼ 6) taking conventional
immuno-suppressive treatment with TNFa antagonists alone or
in association with amino salicilates.
At the time of measurement and since six months before, no
patient was treated with corticosteroids.2.1. Statistical methods
Results are expressed as mean and standard deviation. Statisti-
cal analysis was performed using one-way ANOVA and Man-
neWhitney test to compare data between groups. Chi-squared test
was used for assessing prevalence. Differences were considered
signiﬁcant when P < 0.05.3. Results
Anthropometric measurements of the two groups did not show
signiﬁcant differences for age (33 ± 8.7 vs 33 ± 13 years), height
(168 ± 11 vs 170 ± 8.0 cm), BMI (20.2 ± 2.32 vs 21.5 ± 2.48 kg/m2);
the two groups signiﬁcantly differed for weight (56.9 ± 7.44 vs
62.3± 8.34 kg), fat freemass (40.4± 5.73 vs 48.2± 7.06 kg), fat mass
(17.0 ± 3.55 vs 13.9 ± 5.54 kg) and phase angle (5.6 ± 1.4 vs
6.5 ± 1.0) (Table 1). 25% of patients in G1 (3/12) and 8% in G2 (2/24)
were underweight (BMI< 18.5 kg/m2). The percent of patients with
PA below 5.0 was signiﬁcantly higher in G1 (4/8 patients 50.0%)
compared with G2 (2/24 patients e 8.3%).
REE was signiﬁcantly different between the two groups (G1:
1383 ± 267 vs G2:1582 ± 253 kcal/die) both in men: 1579 ± 314 vs
1640 ± 203 kcal/die andwomen: 1267± 140 vs 1380± 132 kcal/die.
When corrected for FFM, REE was higher in G1 than in G2
(34.8 ± 4.89 vs 33.0 ± 4.35 kcal/kg; p < 0.05) (Table 1). In both
groups of patients REE/FFM was higher than our sex and age
matched reference control group, represented by hospital staff
(120 M: age 30.6 ± 11.5 years, BMI: 22.4 ± 1.3 kg/m2, REE/FFM
30.9 ± 4.5; 110 F: age 29.8 ± 4.5 years, BMI: 21.7 ± 2.4 kg/m2, REE/
FFM 30.2 ± 4.3).
In Table 2 some hematological parameters are reported: basic
inﬂammatory blood parameters were signiﬁcantly higher in G1
than in G2 (hs-RCP (7.76 ± 14.2 vs 7.16 ± 13.4mg/dl); alfa 2-globulin
(11.7 ± 3.69 vs 9.74 ± 2.08 mg/dl); ﬁbrinogen (424 ± 174 vs
334 ± 118 mg/dl) whereas serum albumin values, although within
the normal range, were signiﬁcantly higher in G2 than in G1
(4.2 ± 0.5 vs 3.7 ± 1.1 g/dl).
Prevalence of ﬁbrinogen and alfa 2 globulin above normal limit
was higher in G1 than G2 (G1:50.0% vs G2: 41.7%; 33.3%vs 12.5%
respectively); furthermore prevalence of blood hemoglobin, totalpenditure in adult patients with Crohn's disease, Clinical Nutrition
Table 2
Biochemistry of some routine and inﬂammatory parameters in untreated (group 1) and treated (group 2) CD patients.
Group 1 Group 2
Values out of the
normal range
Values out of the
normal range








Hemoglobin g/dL 12.8 ± 1.6 4/12 (33.3%) 0/12 (0%) 13.5 ± 1.3 3/24 (12.5%) 0/24 (0%)
White cells mL 6496 ± 1694 2/12 (16.7%) 0/12 (0%) 7148 ± 2159 4/24 (16.7%) 2/24 (8.3%)
Lymphocytes mL 1762 ± 656 1/12 (8.3%) 0/12 (0%) 1767 ± 877 3/24 (12.5%) 1/24 (4.2%)
Total Proteins g/dL 6.7 ± 0.9 5/12 (41.7%) 1/12 (8.3%) 7.1 ± 0.7 5/24 (20.8%) 1/24 (4.2%)
Albumin g/dL 3.7 ± 1.1 5/12 (41.7%) 1/12 (8.3%) 4.2 ± 0.5 0/24 (0%) 0/24 (0%)
Hs-CRP mg/dl 7.8 ± 14.2* 6/12 (50.0%) 0/12 (0%) 7.0 ± 13.4 10/24 (41.7%) 0/24 (0%)
Fibrinogen mg/dl 423 ± 174* 0/12 (0%) 6/12 (50.0%) 323 ± 118 1/24 (4.2%) 10/24 (41.7%)
Alfa-2 protein mg/dl 11.7 ± 3.7* 1/12 (8 3%) 4/12 (33.3%) 9.5 ± 2.1 0/24 (0%) 3/24 (12.5%)
*p < 0.05 group 1 vs group 2.
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G2 (33.3% vs 12.5%; 41.7% vs 20.8% and 41.7% vs 0% respectively).4. Discussion
These preliminary results show that REE, when expressed as
absolute value, appears to be higher in CD patients receiving
immuno-suppressive therapy, and characterized by higher total
FFM and phase angle, as compared to pharmacologically untreated
patients. On the other hand, when expressing energy expenditure
as REE/kg FFM we found higher values in untreated patients.
A reasonable explanation for these ﬁndings could be related to
the positive effects of immuno-suppressive therapy that positively
affects, by reducing inﬂammation, total FFM with a proper body
composition. Also FFM characteristics appear to be positively
affected by chronic anti-inﬂammatory therapy as suggested by
higher phase angle recorded in group 2 treated patients. On the
opposite G1 pharmacologically untreated patients tend to show a
“sarcopenic” type of body composition with reduced FFM, also
characterized by a lower phase angle, and increased FAT when
compared to G2 patients.
The effect of immunosuppressive therapy appears therefore
beneﬁcial as far as nutritional status evaluated through energy
expenditure (correctly expressed as REE/kg FFM) and body
composition. Nevertheless we observe that these beneﬁcial effects
due to pharmacological intervention do not completely normalize
Energy Expenditure since patients still show a REE/kg body weight
higher than our age/sex matched control group.
Several studies that have examined the effect of disease activity
in children with Crohn disease have shown either no change
[14e17] or increased REE during active disease [18]; however these
studies have not corrected REE results for body size and composi-
tion. Only Wiskin AE et al [8] found that when expressing energy
expenditure as REE/kg FFM it resulted in higher values for those
with the lowest FFM, therefore this does not seem to represent
hypermetabolism as it has been suggested previously [19e22].
We know that FFM contains both internal organs and skeletal
muscle, organ mass being more metabolically active than skeletal
muscle [23]. In individuals with lower FFM, the relative organ mass
contribution to REE increases thus partially explaining the higher
values of REE while expressed per kg FFM. Nevertheless the
contribution of pro-inﬂammatory factors to this ﬁnding is highly
suspicious as suggested by the reduction of REE/kg FFM in phar-
macologically treated CD patients.
This study has some limitations due to the small number of
subjects examined and the absence of adequate dietary recall. On
the other hand the two groups of patients appear ratherPlease cite this article in press as: Sammarco R, et al., Resting energy ex
(2016), http://dx.doi.org/10.1016/j.clnu.2016.01.005homogenous having been selected among outpatients attending
our Clinical Nutrition Unit in stable clinical and nutritional condi-
tions. From these preliminary ﬁndings we suggest that the
correction of REE related to kg FFM is a more accurate way for the
interpretation of energy expenditure data in CD patients. Chronic
immunosuppressive treatment appears to be beneﬁcial in the long
term for the nutritional status of Crohn disease patients. Careful
nutritional monitoring should be recommended in Crohn disease
patients.
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